Mark Jarowenko
Urology · Lancaster, PANPI 1285666347
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $670 and has fallen 78.0% since, to $147 in 2024. That places this record below the midpoint for urology clinicians in PA, where the typical reported total is $2,187.
Across 93 payments — averaging $21.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$456
- AstraZeneca$442
- Urovant Sciences Inc$342
- Procept Biorobotics Corporation$147
- Boston Scientific$144
- Neotract Inc.$91
- plus $373 from 16 others
What the payments were for
- Food & beverage$1,995100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 32 | $456 |
| AstraZeneca | 23 | $442 |
| Urovant Sciences Inc | 13 | $342 |
| Procept Biorobotics Corporation | 1 | $147 |
| Boston Scientific | 2 | $144 |
| Neotract Inc. | 1 | $91 |
| Olympus America Inc. | 2 | $36 |
| Coloplast | 1 | $34 |
| Merck | 2 | $31 |
| Travere Therapeutics, Inc. | 2 | $31 |
| AbbVie | 1 | $30 |
| Blue Earth Diagnostics | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Johnson & Johnson | 2 | $26 |
| Dendreon Pharmaceuticals LLC | 1 | $22 |
| Baxter Healthcare | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Axonics, Inc. | 1 | $17 |
| Accord Healthcare, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Myovant Sciences Inc. | 1 | $12 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUABEAM SYSTEM$147
- GEMTESA$125
- LithoVue$122
How this compares
$1,995 in reported general payments places this provider in the 45th percentile of 596 urology providers in Pennsylvania.
Other urology in Lancaster
- Paul SieberLancaster$631K
- Christopher MillerLancaster$19K
- John AndersonBethlehem$2.1M
- Demetrius BagleyPhiladelphia$739K
- Daniel EunPhiladelphia$226K
- Leonard GomellaPhiladelphia$190K
- Anthony DimatteoButler$189K
- Angelo BaccalaAllentown$166K
- Phillip GinsbergPhiladelphia$145K
- Edouard TrabulsiPhiladelphia$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.